Design, Synthesis, and Biological Evaluation of (+)-Camphor- and (-)-Fenchone-Based Derivatives as Potent Orthopoxvirus Inhibitors

ChemMedChem. 2022 Jun 20;17(12):e202100771. doi: 10.1002/cmdc.202100771. Epub 2022 Apr 22.

Abstract

In this work, a library of (+)-camphor and (-)-fenchone based N-acylhydrazones, amides, and esters, including para-substituted aromatic/hetaromatic/cyclohexane ring was synthesized, with potent orthopoxvirus inhibitors identified among them. Investigations of the structure-activity relationship revealed the significance of the substituent at the para-position of the aromatic ring. Also, the nature of the linker between a hydrophobic moiety and aromatic ring was clarified. Derivatives with p-Cl, p-Br, p-CF3, and p-NO2 substituted aromatic ring and derivatives with cyclohexane ring showed the highest antiviral activity against vaccinia virus, cowpox, and ectromelia virus. The hydrazone and the amide group were more favourable as a linker for antiviral activity than the ester group. Compounds 3 b and 7 e with high antiviral activity were examined using the time-of-addition assay and molecular docking study. The results revealed the tested compounds to inhibit the late processes of the orthopoxvirus replication cycle and the p37 viral protein to be a possible biological target.

Keywords: (+)-camphor; (−)-fenchone; orthopoxviruses inhibitors; p37 envelope protein; structure-activity relationship.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / chemistry
  • Camphanes
  • Camphor / pharmacology
  • Cyclohexanes
  • Molecular Docking Simulation
  • Norbornanes
  • Orthopoxvirus*

Substances

  • Antiviral Agents
  • Camphanes
  • Cyclohexanes
  • Norbornanes
  • fenchone
  • Camphor